Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence
Cervical cancer is the fourth most common cancer in women worldwide and mainly affects younger women. The mortality associated with cervical cancer can be reduced if this disease is detected at the pre-cancer stage. Current gold standard methods include cytopathology, HPV testing and histopathology but these methods are limited in terms of subjectivity, cost and time. There is an unmet clinical need for new methods to aid clinicians in the early detection of cervical pre-cancer. These methods should be objective, rapid and require minimal sample preparation. Raman spectroscopy is a vibrational spectroscopic technique by which incident radiation is used to induce vibrations in the molecules of a sample and the scattered radiation may be used to characterise the sample in a rapid and non-destructive manner. Raman spectroscopy is sensitive to subtle biochemical changes occurring at the molecular level allowing spectral variations corresponding to disease onset to be detected. Over the past 15 years, there have been numerous reports showing the potential of Raman spectroscopy together with multivariate statistical analysis for the detection of a variety of cancers. This paper discusses the recent advances and issues for cervical cancer screening and diagnosis and offers some perspectives for the future.
Lyng, F. et al. (2015) Raman spectroscopy for screening and diagnosis of cervical cancer”, Analytical and Bioanalytical Chemistry, 407, 8279-8289 (2015). doi:10.1007/s00216-015-8946-1
“Raman spectroscopy for screening and diagnosis of cervical cancer”, Fiona M. Lyng, Damien Traynor, Inês R. M. Ramos, Franck Bonnier and Hugh J. Byrne, Analytical and Bioanalytical Chemistry, 407, 8279-8289 (2015)